Search Results - John Clancy
- Showing 1 - 20 results of 26
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Elexacaftor/tezacaftor/ivacaftor’s effects on cystic fibrosis infections are maintained but not increased after 3.5-years of treatment by Sarah J. Morgan, Ellis Coulter, Hannah L Betts, George M. Solomon, John Clancy, Steven M. Rowe, David P. Nichols, Pradeep K. Singh
Published 2024Artigo -
7
TGF-Beta Downregulation of Distinct Chloride Channels in Cystic Fibrosis-Affected Epithelia by Hongtao Sun, William T. Harris, Stephanie Kortyka, Kavitha Kotha, Alicia J. Ostmann, Amir Akhavan Rezayat, Anusha Sridharan, Yan Y. Sanders, Anjaparavanda P. Naren, John Clancy
Published 2014Artigo -
8
Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study by Harm A.W.M. Tiddens, K. De Boeck, John Clancy, Michaël Fayon, Arets H.G.M., Mark Bresnik, A. Derchak, Sarah Lewis, Christopher M. Oermann
Published 2014Artigo -
9
Doxycycline improves clinical outcomes during cystic fibrosis exacerbations by Xin Xu, Tarek Abdalla, Preston E. Bratcher, Patricia L. Jackson, Gina Sabbatini, J. Michael Wells, Xiang‐Yang Lou, Rebecca Quinn, J. Edwin Blalock, John Clancy, Amit Gaggar
Published 2017Artigo -
10
Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1 by Teerawat Wiwatpanit, Sarah M. Lorenzen, Jorge A. Cantú, Chuan Zhi Foo, Ann Hogan, Freddie Márquez, John Clancy, Matthew J. Schipma, Mary Ann Cheatham, Anne Duggan, Jaime Garcı́a-Añoveros
Published 2018Artigo -
11
NHR-23 activity is necessary for <i>C. elegans</i> developmental progression and apical extracellular matrix structure and function by Londen C. Johnson, An A. Vo, John Clancy, Krista M Myles, Murugesan Pooranachithra, Joseph Aguilera, Max T. Levenson, Chloe Wohlenberg, Andreas Rechtsteiner, James Matthew Ragle, Andrew Chisholm, Jordan D. Ward
Published 2023Artigo -
12
IL-4 Induces Differentiation and Expansion of Th2 Cytokine-Producing Eosinophils by Luqiu Chen, Kristy A. Grabowski, Jun-ping Xin, John M. Coleman, Zan Huang, Baltazar Espiritu, Serhan Alkan, H. Bill Xie, Yuechun Zhu, Fletcher A. White, John Clancy, Hua Huang
Published 2004Artigo -
13
Optimizing Nasal Potential Difference Analysis for CFTR Modulator Development: Assessment of Ivacaftor in CF Subjects with the G551D-CFTR Mutation by Steven M. Rowe, Bo Liu, Aubrey E. Hill, Heather Hathorne, Morty Cohen, John R. Beamer, Frank J. Accurso, Qunming Dong, Claudia L. Ordoñez, Anne J. Stone, Eric R. Olson, John Clancy
Published 2013Artigo -
14
No Detectable Improvements in Cystic Fibrosis Transmembrane Conductance Regulator by Nasal Aminoglycosides in Patients with Cystic Fibrosis with Stop Mutations by John Clancy, Steven M. Rowe, Zsuzsa Bebők, Moira L. Aitken, Ron Gibson, Pamela L. Zeitlin, Pierre Berclaz, Richard B. Moss, Michael R. Knowles, Robert A. Oster, Nicole Mayer-Hamblett, Bonnie W. Ramsey
Published 2007Artigo -
15
Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease by Laura E. Case, Carl Bjartmar, Claire Morgan, Robin Casey, Joel Charrow, John Clancy, Majed Dasouki, Stephanie DeArmey, Khan Nedd, Mary Nevins, Heidi Peters, Dawn Phillips, Zachary Spigelman, Cynthia J. Tifft, Priya S. Kishnani
Published 2014Artigo -
16
Cystic Fibrosis Transmembrane Conductance Regulator Facilitates ATP Release by Stimulating a Separate ATP Release Channel for Autocrine Control of Cell Volume Regulation by Gavin M. Braunstein, Richard M. Roman, John Clancy, Brian A. Kudlow, Amanda L. Taylor, Vadim Gh. Shylonsky, Biljana Jovov, Krisztina Peter, Tamás Jilling, Iskander I. Ismailov, Dale Benos, Lisa M. Schwiebert, Johanna Fitz, Erik M. Schwiebert
Published 2001Artigo -
17
Evaluating the Impact of Stopping Chronic Therapies after Modulator Drug Therapy in Cystic Fibrosis: The SIMPLIFY Clinical Trial Study Design by Nicole Mayer-Hamblett, David P. Nichols, Katherine Odem‐Davis, Kristin A. Riekert, G. Sawicki, Scott H. Donaldson, Félix Ratjen, Michael W. Konstan, Noah Simon, Daniel Rosenbluth, George Retsch‐Bogart, John Clancy, Jill M. VanDalfsen, Rachael Buckingham, Alex H. Gifford
Published 2021Artigo -
18
Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease by Priya S. Kishnani, Deya Corzo, Nancy D. Leslie, Daniel Gruskin, Ans van der Ploeg, John Clancy, Rossella Parini, Gilles Morin, Michael Beck, Mislen Bauer, Mikaël Jokic, Chen-En Tsai, Brian W H Tsai, Claire Morgan, Tara O’Meara, Susan Richards, Elisa Tsao, Hanna Mandel
Published 2009Artigo -
19
Cigarette Smoke Induces Systemic Defects in Cystic Fibrosis Transmembrane Conductance Regulator Function by S. Vamsee Raju, Patricia L. Jackson, Clifford Courville, Carmel M. McNicholas, Peter A. Sloane, Gina Sabbatini, Sherry Tidwell, Li Tang, Bo Liu, James A. Fortenberry, Caleb Jones, Jeremy A. Boydston, John Clancy, Larry E. Bowen, Frank J. Accurso, J. Edwin Blalock, Mark T. Dransfield, Steven M. Rowe
Published 2013Artigo -
20
Multicenter Intestinal Current Measurements in Rectal Biopsies from CF and Non-CF Subjects to Monitor CFTR Function by John Clancy, Rhonda D. Szczesniak, Melissa A. Ashlock, Sarah E. Ernst, Lijuan Fan, Douglas B. Hornick, Philip H. Karp, Umer Khan, James Lymp, Alicia J. Ostmann, Amir Akhavan Rezayat, Timothy D. Starner, Shajan P. Sugandha, Hongtao Sun, Nancy L. Quinney, Scott H. Donaldson, Steven M. Rowe, Sherif E. Gabriel
Published 2013Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Cystic fibrosis
Biology
Cystic fibrosis transmembrane conductance regulator
Gene
Genetics
Ivacaftor
Cell biology
Pathology
Clinical trial
Intensive care medicine
Antibiotics
Biochemistry
Chemistry
Lung
Randomized controlled trial
Alternative medicine
Anatomy
Bacteria
Disease
Gastroenterology
Immunology
Microbiology
Pseudomonas aeruginosa
Asthma
Cell
Chloride channel
Cochlea
Computer science